SEC Form 4 · accession 0002126940-26-000004
ImageneBio, Inc. · IMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert B Lally
Officer — Principal Accounting Officer
Period of report
Jul 16, 2026
Accepted (ET)
Jul 20, 2026 · 9:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001835579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 16, 2026 | S | 1,671 | $5.50 | D | 57,107 | D | |
| Common StockF2 | Jul 17, 2026 | S | 1,525 | $5.34 | D | 55,582 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.32 to $5.3527, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.